This page shows the latest US Congress news and features for those working in and with pharma, biotech and healthcare.
Drug pricing will also be a focus of the incoming President-elect, Joe Biden, who has promised to reduce drug prices in the US. ... Despite the ongoing debate around drug pricing in the US Congress, it is expected that further drug price increases are to
A new US start-up says it has a plan to completely revamp the approach to drug development, allowing to launch drugs more quickly and at a lower cost. ... Bach recently proposed a model for selecting drugs for pricing negotiations with Medicare – a
Gun violence in the US – a public health issue – can be better understood through three points. ... The first one is actually simpler to answer. In 1996, the US congress passed the Dickey Amendment which was, effectively, a response to the Centers
A study presented at the Mass Spectrometry Applications to the Clinical Lab (MSACL) congress in the US last week by Roche and Biognosys scientists looked at how ‘discovery proteomics’ performed in
This included a $3bn fine imposed on GSK after it was caught promoting Advair off-label in the US, with a corporate integrity agreement imposed on it by US regulators. ... It will also return to paying travel costs for HCPs to attend GSK’s own
The US regulator's Orphan Drug Modernisation Plan aims to eliminate the waiting list, and is the first development under the FDA's new Medical Innovation Development Plan. ... Congress gave us tools to incentivise the development of novel therapies for
More from news
Approximately 1 fully matching, plus 29 partially matching documents found.
Achaogen and Aradigm filed for bankruptcy in 2019, and Melinta did the same at the start of 2020, despite heavy investment from the US Biomedical Advanced Research and Development Authority (BARDA). ... The same approach is currently proposed in a bill
One option is to completely reconfigure the congress model – by thinking about time in a different way. ... What’s more, when the pandemic is behind us, congress communities are unlikely to walk back on the progress they’ve made or the mindset
A much-talked-about initiative in the United States is the Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act which advocates hope to get through the US Congress in ... July 2019 saw us take forward an anti-
A US survey that has been undertaken every year since the early 1990s provides some illumination as to the specialties that residents and fellows completing their training in New York State ... A brief glance at the programme for the major US haematology
More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.
Another congress attended in this virtual world with learnings gathered and connections made across the rare disease community. ... In conclusion, this congress has ‘US’ tagged to its name but it is very clear from the dialogue that we face Global
We asked Becca McConnell to give us an insight into her role as Senior Account Executive at OPEN Health. ... OPEN Health attend EB World Congress—building on momentum and strength in numbers for epidermolysis bullosa.
A US survey that has been undertaken every year since the early 1990s provides some illumination as to the specialties that residents and fellows completing their training in New York State ... A brief glance at the programme for the major US haematology
Join us at EULAR Congress 2017 in Madrid, 14-17 June. We are delighted to be attending and presenting at this year’s EULAR Annual European Congress of Rheumatology in June.
Research Partnership is today expanding its US operations across both the West and East Coast. ... Visit us on stand number 14. Join us at EULAR Congress 2017 in Madrid, 14-17 June.
More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.
We are a global leader in the medical affairs space. Our purpose-built software and scientific solutions make us a unique...